Multiple sclerosis (MS) treatment in adults depends on the type of MS, how active the disease is and which symptoms are affecting daily life. There is currently no cure for MS, but modern treatment can reduce relapses, limit new inflammatory damage and, in some forms of MS, slow disability progression.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Adult MS treatment usually has three main goals:
- Control the underlying disease with disease-modifying therapy
- Treat significant relapses when they occur
- Manage symptoms such as fatigue, stiffness, pain and mobility problems
For a broader overview of the condition, see our main guide to Multiple Sclerosis (MS) Treatment.
What Is the Best Treatment for MS in Adults?
There is no single best treatment for every adult with MS. The first question is usually: What type of MS does the person have, and is the disease currently active?
| Type of MS | Main Treatment Approach |
|---|---|
| Relapsing MS | Disease-modifying therapy to reduce relapses and new inflammatory activity |
| Primary progressive MS | Treatment aimed at slowing progression in suitable patients, plus rehabilitation and symptom management |
| Secondary progressive MS with active inflammation | Selected disease-modifying treatments may be appropriate |
| Non-relapsing progressive MS | Options are more limited, although new treatments are emerging in some countries |
1. Should Adults Start With a High-Efficacy MS Treatment?
Traditionally, many people started with a moderately effective treatment and moved to a stronger medicine only if MS remained active. That approach is changing. Updated Association of British Neurologists guidance recommends offering people with active MS appropriate treatment as early as possible and considering high-efficacy therapy first when the disease or individual risk profile justifies it.
This may be particularly relevant when there are signs such as:
- Frequent or severe relapses
- Significant MRI activity
- Early disability accumulation
- Other features suggesting more active disease
Higher-efficacy treatment is not automatically best for everyone because stronger immune effects can also bring greater monitoring requirements and potential risks.
2. Treatment for Relapsing Multiple Sclerosis
Relapsing MS involves episodes of new or worsening neurological symptoms, often separated by periods of partial or complete recovery. DMTs are particularly important because they can reduce inflammatory disease activity. If relapses or new MRI lesions continue despite treatment, the neurologist may consider:
- Whether the medicine is being taken correctly
- Whether the treatment has had enough time to work
- Switching to another DMT
- Moving to a higher-efficacy treatment
3. Treatment for Primary Progressive MS
Primary progressive MS (PPMS) causes gradual worsening from the beginning rather than clearly separated relapses. Treatment options are more limited than for relapsing MS. Ocrelizumab is an established disease-modifying option for selected adults with early PPMS and evidence of inflammatory activity under current European and UK guidance.
For adults with progressive MS, treatment also places strong emphasis on:
- Physiotherapy
- Mobility
- Strength and balance
- Spasticity management
- Pain control
- Bladder and bowel care
- Maintaining independence
4. Treatment for Secondary Progressive MS
Some people who initially have relapsing MS eventually develop secondary progressive MS (SPMS), where disability gradually increases over time. If SPMS remains active—with relapses or inflammatory MRI changes—disease-modifying treatment may still help. For example, siponimod is an established option for adults with active SPMS in several regions.
A major recent development is tolebrutinib, which received European Union authorisation in June 2026 for adults with SPMS who have had no relapses during the previous two years. This is an evolving area of MS treatment, and availability differs between countries. Tolebrutinib also requires liver-function monitoring because liver injury is an identified safety risk.
5. How Are MS Relapses Treated?
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
A relapse is a new neurological symptom or significant worsening of an existing symptom caused by new inflammatory MS activity. Not every relapse requires steroids. If a relapse significantly interferes with normal activities, high-dose methylprednisolone may be prescribed to speed recovery.
Steroids can shorten the duration of a relapse, but they do not act as long-term disease-modifying treatment. Before diagnosing a relapse, clinicians may also need to rule out problems such as infection, because fever or infection can temporarily worsen existing MS symptoms without representing new inflammatory disease.
6. Treating MS Symptoms in Adults
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Disease-modifying medicines do not necessarily improve symptoms that are already present. Adults may therefore need additional treatment for specific problems.
| MS Symptom | Possible Management |
|---|---|
| Fatigue | Activity planning, exercise, sleep assessment and treatment of contributing causes |
| Spasticity | Physiotherapy, stretching and medication when needed |
| Nerve pain | Medicines used specifically for neuropathic pain |
| Walking difficulty | Physiotherapy, mobility aids and rehabilitation |
| Bladder problems | Bladder assessment, behavioural strategies and medication when appropriate |
| Speech or swallowing problems | Speech and language therapy |
| Cognitive difficulties | Cognitive assessment, rehabilitation and practical compensatory strategies |
7. Rehabilitation Is Part of MS Treatment
Rehabilitation becomes especially important when MS affects mobility, balance, work or everyday independence. A multidisciplinary programme may include:
- Physiotherapy
- Occupational therapy
- Speech and language therapy
- Cognitive rehabilitation
- Mobility and assistive devices
Exercise is generally encouraged in people with MS and does not cause the disease to progress.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
What About Stem Cell Treatment for MS?
Autologous haematopoietic stem cell transplantation (AHSCT) is sometimes considered for carefully selected adults with highly active inflammatory MS that has not been adequately controlled with appropriate DMTs. AHSCT uses intensive treatment to suppress the existing immune system, followed by reinfusion of the person's own blood-forming stem cells.
It is not a routine treatment for every person with MS and carries important short- and long-term risks. It should only be considered through an experienced specialist MS and transplant team.
The Bottom Line
Multiple sclerosis treatment for adults is built around the person's MS type, disease activity and individual risk of future disability. For adults with active relapsing MS, disease-modifying treatment should generally be considered early. Some people can begin with standard therapies, while adults with more active disease may benefit from high-efficacy treatment earlier in the disease course.
Progressive MS requires a different approach. Ocrelizumab can be used for selected adults with primary progressive MS, while treatments such as siponimod may be appropriate for active secondary progressive MS. Newer options are also emerging for non-relapsing progressive disease. Relapses, fatigue, spasticity, pain, bladder problems and mobility difficulties need their own treatment alongside the DMT.
The best adult MS treatment is therefore not one medicine—it is a long-term plan that controls disease activity, treats symptoms, protects function and changes when the disease or the person's needs change.
